(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSTOS ANTAGONISTAS DE RECEPTOR DE ADENOSINA, FORMULAÇÃO FARMACÊUTICA COMPREENDENDO OS MESMOS, SEUS USOS E SEU PROCESSO DE PREPARAÇÃO

Em ExigênciaInvention PatentPCT · US2019020810

Application data

Number

112020018158

Type

Invention Patent

Filing

03/05/2019

Publication

02/02/2021

PCT

US2019020810

Progress at the INPI

Technical opinion to answer
  1. Filing03/05/19
  2. Publication02/02/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/04/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TEON THERAPEUTICS, INC.

US

Inventors

E. E. (pessoa física)

US

J. L. (pessoa física)

US

Technical data

Priority claims

US

62/638,737 · 03/05/2018

US

62/688,088 · 06/21/2018

Abstract

ANTAGONISTAS DE RECEPTOR DE ADENOSINA E USOS DOS MESMOS.São divulgados aqui compostos, composições, formulações e métodos para modular o receptor de adenosina A2B.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Republicação - classificação IPC

#15.11

As Classificações Anteriores eram: C07D 473/06 , C07F 9/6561

06/04/2024

RPI 2787

Parecer de pré-exame

#6.23

03/21/2023

RPI 2724

Adição na publicação

#15.35

12/14/2021

RPI 2658

Notificação de entrada na fase nacional - PCT

#1.3

02/02/2021

RPI 2613

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.